Anrotinib and Tirelizumab in First-line Treatment of RM-NPC
Clinical trial NCT05981157 · UNKNOWN
Trial details
- NCT number
- NCT05981157
- Sponsor
- Zhongshan People's Hospital, Guangdong, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2025-12-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.